SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Eikon Therapeutics CEO to Participate in November Investor Conferences

CEO Roger M. Perlmutter is scheduled to participate in the Guggenheim 3rd Annual Healthcare Innovation conference.

EIKN

Related stories